Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

Three phase II randomized trials evaluated the safety/immunogenicity of two formulations of live-attenuated tetravalent dengue virus (TDEN) vaccine in dengue-endemic (Puerto Rico, Thailand) and non-endemic (US) regions (NCT00350337/NCT00370682/NCT00468858). We describe cell-mediated immune (CMI) res...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Hum Vaccin Immunother
Prif Awduron: Moris, Philippe, Bauer, Kristen M., Currier, Jeffrey R., Friberg, Heather, Eckels, Kenneth H., Esquilin, Ines O., Gibbons, Robert V., Innis, Bruce L., Jarman, Richard G., Simasathien, Sriluck, Sun, Peifang, Thomas, Stephen J., Watanaveeradej, Veerachai
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2019
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773406/
https://ncbi.nlm.nih.gov/pubmed/30829100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1581536
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg